Purification and biochemical properties of soluble recombinant human Bax

被引:27
作者
Lewis, S
Bethell, SS
Patel, S
Martinou, JC
Antonsson, B
机构
[1] Glaxo Wellcome R&D SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
[2] Glaxo Wellcome Res & Dev Ltd, Biomol Struct Unit, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1006/prep.1997.0871
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bax is a member of the Bcl-2 protein family with proapoptotic properties. The proteins of this family contain three highly conserved regions termed BH1, BH2, and BH3 as well as a hydrophobic COOH-terminal domain, which is responsible for the membrane attachment of the proteins. We have expressed human Bax truncated of the 20 amino acid COOH-terminal hydrophobic domain to obtain large amounts of soluble protein suitable for biochemical and structural studies. The truncated protein was expressed as a glutathione S-transferase (GST) fusion protein in Escherichia coli. The GST-Bax fusion protein was bound to glutathione-Sepharose, and Bax was released by thrombin cleavage and further purified by sequential chromatography on heparin-Sepharose and DEAE-Sepharose. The purified protein was present in solution as a heptamer and multimers of the heptamer complex. Limited tryptic digestion cleaved the protein in the region preceding the BH3 domain and produced a specific stable protein fragment of 15 kDa. Phosphorylation has been proposed as a possible regulatory mechanism of the bcl-2 proteins. The Bax protein was an in vitro substrate for specific serine/threonine protein kinases. (C) 1998 Academic Press.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 29 条
  • [1] Inhibition of Bax channel-forming activity by Bcl-2
    Antonsson, B
    Conti, F
    Ciavatta, A
    Montessuit, S
    Lewis, S
    Martinou, I
    Bernasconi, L
    Bernard, A
    Mermod, JJ
    Mazzei, G
    Maundrell, K
    Gambale, F
    Sadoul, R
    Martinou, JC
    [J]. SCIENCE, 1997, 277 (5324) : 370 - 372
  • [2] BERNARD AR, 1995, CURRENT PROTOCOLS PR
  • [3] DISSECTION OF FUNCTIONAL DOMAINS IN BCL-2-ALPHA BY SITE-DIRECTED MUTAGENESIS
    BORNER, C
    OLIVER, R
    MARTINOU, I
    MATTMANN, C
    TSCHOPP, J
    MARTINOU, JC
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 1994, 72 (11-12) : 463 - 469
  • [4] HIGH EXPRESSION OF LATENT MEMBRANE-PROTEIN-1 OF EPSTEIN-BARR-VIRUS AND BCL-2 ONCOPROTEIN IN ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED PRIMARY BRAIN LYMPHOMAS
    CAMILLERIBROET, S
    DAVI, F
    FEUILLARD, J
    BOURGEOIS, C
    SEILHEAN, D
    HAUW, JJ
    RAPHAEL, M
    [J]. BLOOD, 1995, 86 (02) : 432 - 435
  • [5] Phosphorylation of Bcl-2 protein and association with p21(Ras) in Ras-induced apoptosis
    Chen, CY
    Faller, DV
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) : 2376 - 2379
  • [6] COHN EJ, 1943, PROTEINS AMINO ACIDS, pCH4
  • [7] delPeso L, 1997, SCIENCE, V278, P687
  • [8] DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, pCH3
  • [9] New members of the Bcl-2 family and their protein partners
    Farrow, SN
    Brown, R
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) : 45 - 49
  • [10] INACTIVATION OF BCL-2 BY PHOSPHORYLATION
    HALDAR, S
    JENA, N
    CROCE, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) : 4507 - 4511